The European Patent Office (EPO) has published patent application EP3532491A1, titled 'Fish skin collagen peptides composition and drug use'. This publication, dated March 11, 2026, lists Gelatines Weishardt as the applicant and details the inventors. The patent covers specific compositions of fish skin collagen peptides and their application as a drug.

This is a patent publication, not a regulatory rule or guidance that imposes direct compliance obligations on companies. However, it is relevant for pharmaceutical and drug development companies operating within the EU, particularly those involved in collagen-based therapeutics or research. Companies should monitor patent filings in their areas of interest for potential intellectual property implications.